Antihemophilic Factor (Recombinant [Fc Fusion Protein]) e Lithium Controlled-Release and Extended-Release Tablets
Definición de la interacción Antihemophilic Factor (Recombinant [Fc Fusion Protein]) e Lithium Controlled-Release and Extended-Release Tablets y posibilidad de tomarlos juntos.
Entre los medicamentos elegidos no se encontró interacción o los efectos del uso combinado de farmacos actualmente no se han estudiado lo suficiente, se necesita de las estadísticas acumuladas y de tiempo para definir su interacción. Para decidir si se pueden tomar ambos medicamentos se necesita una consulta médica.
Nombre genérico: antihemophilic factor
Marca comercial: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Sinónimos: Antihemophilic factor (human), Antihemophilic Factor (Human)
Nombre genérico: lithium
Marca comercial: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Sinónimos: Lithium
Durante la verificación se utilizó información de las siguientes fuentes: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithium ER
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithium Oral Solution
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithium Salts
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithium Syrup and Oral Solution
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithobid
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant [Pegylated])
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant) (Advate)
- Lithium Controlled-Release and Extended-Release Tablets-Antihemophilic Factor (Recombinant) (Afstyla)